宫颈癌CT引导自适应近距离放疗靶区勾画:IBS-GEC ESTRO-ABS联合推荐
MR是宫颈癌图像引导自适应近距离放疗(IGABT)的金标准,但受可及性、后勤和费用限制。IBS、GEC ESTRO和ABS基于ICRU第89号报告的概念与术语,联合制定了CT引导IGABT靶区定义与勾画的系统化、统一化国际推荐,以改善CT(及US、MRI)条件下的勾画准确性。
要点
- CT引导IGABT靶区勾画需基于诊断时和BT时的GTV评估,并将外照射反应分为不同临床缓解模式。
- 推荐将临床-影像环境分为8类、缓解类别分为4类,分别对应不同的勾画不确定性与靶区定义。
- 最低要求包括临床检查与记录、诊断时CT或MR成像、以及置入施源器后的CT成像。
核心结论
- 基于4类缓解类别和8种临床-影像环境的CT靶区勾画推荐,旨在提高CT(以及US、MRI)条件下IGABT的勾画准确性。
- 针对每种临床-影像环境尽量减少特定不确定性,以获得尽可能最佳的勾画准确性。
- 下一步将评估可行性与可重复性,以MR IGABT为金标准基准,并开展CT引导IGABT结局的进一步临床研究。
研究设计与样本
- 由IBS、GEC ESTRO和ABS联合制定的国际推荐,基于ICRU第89号报告已发表的概念与术语。
- 推荐基于以下要素:诊断时和近距离放疗时GTV评估、外照射后临床缓解模式分类、临床-影像环境定义、以及施源器在位时CT靶区定义与勾画。
- 最低要求为临床检查与记录、诊断时CT或MR成像、以及至少置入施源器后的CT成像。
诊断标准与关键数值
- 靶区勾画按4类缓解类别和8种定义环境进行分层推荐。
- 诊断时和近距离放疗时均需评估GTV。
- 外照射反应按不同临床缓解模式进行分类。
临床应用与阅片要点
- 在施源器在位时行CT成像,并据此勾画靶区。
- 需结合诊断时影像评估GTV,并记录临床检查结果。
- 按缓解类别和临床-影像环境选择相应勾画策略,以减少特定不确定性。
局限性
- MR仍为金标准,CT引导IGABT的可行性与可重复性尚待评估。
- CT引导IGABT的结局证据有待进一步临床研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
MR Imaging is regarded asthe gold standardfor Image Gudied Adaptive Brachytherapy (IGABT) for cervical cancer. However, its wide applicability is limited by its availability, logistics and financial implications. Use of alternative imaging like CTand Ultrasound (US) for IGABT has been attempted. In order to arrive at a systematic, uniform and international approach for CT based definition and contouring of target structures, GEC ESTRO, IBS and ABS agreed to jointly develop such recommendations based on the concepts and terms as published in the ICRU Report 89. The minimum requirements are clinical examination & documentation, CT or MR imaging at diagnosis and at a minimum, CT imaging with the applicator in place. The recommendations are based on (i) assessment of the GTV at diagnosis and at brachytherapy, (ii) categorizing the response to external radiation into different clinical remission patterns, (iii) defining various clinico-radiological environments and (iv) definition & delineation of a target on CT imaging at the time of brachytherapy with the applicator in situ. CT based target contouring recommendations based on 4 remission categories within 8 defined environments, aim at improving the contouring accuracy for IGABT using CT, US and MRI as available. For each clinico-radiological environment, there is an attempt to minimize the specific uncertainties in order to arrive at the best possible contouring accuracy. Evaluating feasibility & reproducibility, to achieve a benchmark towards a gold standard MR IGABT and further clinical research including outcomes with CT Based IGABT will become the next steps.
引用
- Mahantshetty U, Poetter R, Beriwal S, et al. IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer. Radiother Oncol. 2021. PMID: 34019918. doi:10.1016/j.radonc.2021.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。